
- © Claudio Punzo
- , et al.
- 2022
Advances in Gene Therapy for Diseases of the Eye
- Claudio Punzo 1
- Hemant Khanna 1
- Lolita Petit 2
- 1 - Department of Neurobiology - University of Massachusetts Medical School - Worcester Massachusetts
- 2 - Department of Ophthalmology and Gene Therapy Center - University of Massachusetts Medical School - Worcester Massachusetts
Jun 24, 2022
Abstract
Over the last few years, huge progress has been made with regard to the understanding of molecular mechanisms underlying the pathogenesis of neurodegenerative diseases of the eye. Such knowledge has led to the development of gene therapy approaches to treat these devastating disorders. Challenges regarding the efficacy and efficiency of therapeutic gene delivery have driven the development of novel therapeutic approaches, which continue to evolve the field of ocular gene therapy. In this review article, we will discuss the evolution of preclinical and clinical strategies that have improved gene therapy in the eye, showing that treatment of vision loss has a bright future.
Related Content
-
Primer
Orthogonal Validation in Genome Editing Discovery Work -
Primer
Solvent Precipitation Method Increases Protein Recovery for Proteomics -
Protocol
Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47phox-Deficient Chronic Granulomatous Disease -
Protocol
High-Throughput In Vitro, Ex Vivo, and In Vivo Screen of Adeno-Associated Virus Vectors Based on Physical and Functional Transduction -
Protocol
Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells - More
Comments
Be the first to comment on this protocol.